Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,206 recalls · Class II, newest first

Class II · Moderate risk

Dextroamphetamine Saccharate

Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Terminated Labeling / mix-up Teva Pharmaceuticals USA Inc NDC 0555-0777-02 D-1539-2022
Class II · Moderate risk

Neomycin Sulfate Tablets

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA Inc NDC 0093-1177-01 D-1473-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 69097-341-35 D-1499-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 76282-708-50 D-1498-2022
Class II · Moderate risk

Triamcinolone Acetonide Cream USP

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Terminated cGMP deviation Padagis US LLC NDC 45802-064-36 D-1497-2022

Recalls by year